Seres Therapeutics GAAP EPS of $0.94 beats by $0.52, revenue of $0.35M
Source: SeekingAlpha
2025-11-05 07:14:15 ET
More on Seres Therapeutics
- Seres Therapeutics cuts 25% of workforce to extend cash runway into Q2 2026
- Biggest stock movers Monday: RAPP, MCRB, SATS, QS, SMMT and more
- Seeking Alpha’s Quant Rating on Seres Therapeutics
- Historical earnings data for Seres Therapeutics
- Financial information for Seres Therapeutics
Read the full article on Seeking Alpha
For further details see:
Seres Therapeutics GAAP EPS of $0.94 beats by $0.52, revenue of $0.35M
Seres Therapeutics Inc.
NASDAQ: MCRB
MCRB Trading
-0.46% G/L:
$8.69 Last:
19,989 Volume:
$9 Open:
MCRB Latest News
March 12, 2026 07:00:00 am
Seres Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
MCRB Stock Data
$129,727,082
7,418,146
0.38%
16
N/A
Biotechnology & Life Sciences
Healthcare
US
Cambridge
